BIOMAT Database Logo BIOMAT Database Logo

Renewed role of nuclear medicine in renovascular hypertension. 1988

M D Blaufox, and L M Freeman
Department of Nuclear Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10461.

The role of nuclear medicine in the differential diagnosis of renovascular hypertension has been subject to considerable disagreement. The renogram has several distinct advantages as a diagnostic test, among which are the following: it is safe, easily performed, and has a high sensitivity for the differentiation of normal renal function from abnormal renal function. The use of the captopril renogram is based on the observation that renal function appears to be maintained in renovascular hypertension through a component of the renin-angiotensin system. Captopril renography will greatly improve the efficacy of the radionuclide renogram in the differential diagnosis of renovascular hypertension.

UI MeSH Term Description Entries
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M D Blaufox, and L M Freeman
Renovascular hypertension: nuclear medicine techniques.
December 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
M D Blaufox, and L M Freeman
[Nuclear medicine in the study of renovascular hypertension].
August 1999, Revista espanola de medicina nuclear,
M D Blaufox, and L M Freeman
[Endocrine and nuclear medicine diagnosis of renovascular hypertension].
November 1989, Deutsche medizinische Wochenschrift (1946),
M D Blaufox, and L M Freeman
Cost-effectiveness of nuclear medicine procedures in renovascular hypertension.
April 1989, Seminars in nuclear medicine,
M D Blaufox, and L M Freeman
The role and rationale of nuclear medicine procedures in the differential diagnosis of renovascular hypertension.
January 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
M D Blaufox, and L M Freeman
Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine.
July 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M D Blaufox, and L M Freeman
Differential diagnosis and management of renovascular hypertension through nuclear medicine techniques.
April 1989, Seminars in nuclear medicine,
M D Blaufox, and L M Freeman
[The role of nuclear medicine in renovascular pathology of urologic significance].
June 1992, Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences,
M D Blaufox, and L M Freeman
Clinical problems in renovascular disease and the role of nuclear medicine.
March 2014, Seminars in nuclear medicine,
M D Blaufox, and L M Freeman
Renewed energy for nuclear medicine and molecular imaging.
August 2011, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!